Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix

被引:59
作者
de Gruijl, TD
Bontkes, HJ
van den Muysenberg, AJC
van Oostveen, JW
Stukart, MJ
Verheijen, RHM
van der Vange, N
Snijders, PJF
Meijer, CJLM
Walboomers, JMM
Scheper, RJ
机构
[1] Free Univ Amsterdam Hosp, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Haematol, NL-1007 MB Amsterdam, Netherlands
[3] Free Univ Amsterdam Hosp, Dept Obstet & Gynaecol, NL-1007 MB Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Gynaecol, Amsterdam, Netherlands
关键词
human papillomavirus; cervical neoplasia; cytokines; T cell; RT-PGR; IL-12; IL-10; IFN gamma;
D O I
10.1016/S0959-8049(98)00371-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the expression of cytokine transcripts, reflecting the type of ongoing immune responses at the site of human papillomavirus (HPV) infection, in relation to the development of cervical neoplasia. To this end reverse transcription-polymerase chain reaction (RT-PCR) was performed for interferon (IFN)gamma, interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12 (p35 and p40), and transforming growth factor (TGF beta 1) in snap-frozen cervical biopsies, which were tested for the presence of high risk HPV DNA and histologically classified from normal to invasive carcinoma (n = 40). IFN gamma, IL-10 and IL-12 (p35 and p40) transcripts were found to be expressed at significantly lower frequencies in invasive carcinoma as compared with premalignant biopsies (P=0.006, P=0.007 and P=0.002, respectively). IFN gamma and IL-10 mRNA were associated with the presence: of the IL-12 p35 and p40 transcripts (P=0.008 and P<0.00001, respectively), These results are consistent with a locally reduced cellular (type 1) immunity correlating with HPV-induced invasive cervical carcinoma. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:490 / 497
页数:8
相关论文
共 33 条
[1]  
[Anonymous], IARC MON EV CARC RIS
[2]   TGF beta 1 regulates gene expression of its own converting enzyme furin [J].
Blanchette, F ;
Day, R ;
Dong, W ;
Laprise, MH ;
Dubois, CM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08) :1974-1983
[3]   Type 1 and Type 2: A fundamental dichotomy for all T-cell subsets [J].
Carter, LL ;
Dutton, RW .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) :336-342
[4]   Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma [J].
Caruso, M ;
PhamNguyen, K ;
Kwong, YL ;
Xu, BS ;
Kosai, KI ;
Finegold, M ;
Woo, SLC ;
Chen, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11302-11306
[5]   Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection [J].
Clerici, M ;
Merola, M ;
Ferrario, E ;
Trabattoni, D ;
Villa, ML ;
Stefanon, B ;
Venzon, DJ ;
Shearer, GM ;
DePalo, G ;
Clerici, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :245-250
[6]  
Daftarian PM, 1996, J IMMUNOL, V157, P12
[7]   Immunology of papillomavirus infection [J].
Frazer, IH .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :484-491
[8]   Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 [J].
Gerosa, F ;
Paganin, C ;
Peritt, D ;
Paiola, F ;
Scupoli, MT ;
AsteAmezaga, M ;
Frank, I ;
Trinchieri, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2559-2569
[9]   ANALYSIS OF CYTOMORPHOLOGICALLY ABNORMAL CERVICAL SCRAPES FOR THE PRESENCE OF 27 MUCOSOTROPIC HUMAN PAPILLOMAVIRUS GENOTYPES, USING POLYMERASE CHAIN-REACTION [J].
HUSMAN, AMD ;
WALBOOMERS, JMM ;
MEIJER, CJLM ;
RISSE, EKJ ;
SCHIPPER, MEI ;
HELMERHORST, TM ;
BLEKER, OP ;
DELIUS, H ;
VANDENBRULE, AJC ;
SNIJDERS, PJF .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) :802-806
[10]  
HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057